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Abstract. Human sparganosis is a cestode infection which is neglected as a differential diagnosis outside endemic
countries. Diagnosis and therapy may be challenging depending on the clinical presentation and anatomic localization.
The disease manifests predominantly as subcutaneous nodule(s) or intracranial mass lesion(s). Infection is primarily
acquired by ingesting raw or undercooked amphibian or reptile ﬂesh or by drinkingwater containing copepods.We report
an unusual case of subcutaneousSpirometra erinaceieuropaei sparganosis presenting with two nonmigratory nodules in
close proximity to each other on the right thigh of a Thai woman living in Switzerland.
CASE REPORT
In June 2018, a 55-year-old Thai woman living for the last
25 years in Switzerland presented with a history of two sub-
cutaneous, painless, nonitching nodules to a dermatologist in
Switzerland. The nodules had been present for 4 years, and the
patient reported neither growth nor change ofmorphology over
time. On palpation, two ﬁrm subcutaneous nodules of coarse
consistency, both measuring approximately 4 cm in diameter,
locatedon the right upper thigh in close proximity to eachother,
were identiﬁed. Neither signs of inﬂammation nor local lymph-
adenopathy was present, and the physical examination was
otherwise unremarkable. Basic laboratory investigations (in-
cluding differential blood count, C-reactive protein, and liver
function tests) were all within normal limits. Because the clinical
presentation suggested a benign soft tissue process, imaging
was dispensed under the assumption that deﬁnite diagnosis
would be established by surgical excision and histological ex-
amination. Hence, the patientwas referred to a plastic surgeon.
On incision of the ﬁrst nodule, a whitish, thin, ﬂattened, worm-
like object (∼0.3 × 15 cm) was pulled out. On incision of the
second nodule, a morphologically similar structure was re-
moved (Figure 1). (Note: Because of the unexpected ﬁndings at
incision of the ﬁrst nodule, the second nodule was operated on
10 days later, after our laboratory had been consulted and a
provisional diagnosis had been established.)
Because the ﬁndings were suspicious of a helminth, two
samples (one from the ﬁrst resected worm ﬁxed in formalin and
the other one from the second resected worm stored in normal
saline solution) were sent to the National Reference Center for
HumanParasiticDiseasesat theSwissTropical andPublicHealth
Institute in Basel. Macroscopic and microscopic investigation of
the sample stored in normal saline solution showed an amor-
phous structure exhibiting slow, undulating movements. An an-
terior end was identiﬁed by ﬁnding an oral opening of a helminth,
whereas the posterior end was disrupted. A part of the sample
was embedded in parafﬁn and used for histological investigation,
which revealed typical characteristics of spargana: a folded cuti-
cula with microvilli and calcareous corpuscles (Figure 2). For
species determination, DNAwas isolated fromanother part and a
sequence of the mitochondrial cytochrome oxidase (COX1)
genewas ampliﬁedand sequenced as described elsewhere.1 A
398–base pair-long sequence of the COX1 was determined
(GenBank accession number MK910864) showing 100%,
99.25%, and 90.20% sequence homology to Spirometra eri-
naceieuropaei (no single nucleotide polymorphisms [SNPs]),
Spirometradecipiens (3SNPs), andSparganumproliferum (>35
SNPs), respectively (Figure 3). Thus, the helminthwas identiﬁed
as S. erinaceieuropaei. The healing of the wounds proceeded
without complications. No oral anthelminthic treatment was
administered, and no subsequent lesions occurred since.
DISCUSSION
Sparganosis is a rare zoonotic cestode infection caused by
the second-stage larva of various species of the pseudophylli-
dean tapeworm Spirometra spp. In the Old World, S. erina-
ceieuropaei causes most infections, whereas Spirometra
mansonoides is mostly prevalent in the NewWorld.2,3
Approximately 1,600 human cases have been reported
worldwide since the ﬁrst case description in 1882 in Xiamen,
Fujian Province, China. More than 80%of all cases have been
reported from China, followed by Korea, Thailand, and the
United States.4
The parasite’s life cycle is similar to that of the ﬁsh tapeworm
Diphyllobothrium spp. Carnivorous mammals serve as deﬁnite
hosts, harboring the adult worm in the intestine and shedding
eggs in their feces.When eggs get into freshwater, they release
coracidia. Coracidia are ingested by copepods, the ﬁrst inter-
mediate host, and develop into procercoid larvae (ﬁrst-stage
larvae) within 3–11 days.5 When the copepod is ingested by
ﬁsh, reptiles, or amphibians, the second intermediate hosts,
procercoid larvae develop into plerocercoid larvae (second-
stage larvae, “sparganum”), lodging in various body tissues.
When the second intermediate host is ingested by the deﬁnite
host, plerocercoid larvae develop into adult worms in its intes-
tine. In addition, several predator species may serve as para-
tenic hosts (Figure 4). Humans are accidental hosts and
become infected by ingesting raw or undercooked second in-
termediate hosts or by drinking untreated water contaminated
with infected copepods. In some Asian countries, the applica-
tionof poultices,made fromsecond intermediatehosts, on skin
or eyeshasbeen reportedas an alternative source of infection.4
Usually, humans are dead-end hosts in which larvae do not
reach patency. However, in rare cases, eggs have been found
in human feces.6
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The incubation period in humans varies from several days
up to years.7 The clinical picture depends on the ﬁnal desti-
nation of the migrating spargana. Subcutaneous tissue, as
well as abdominal viscera, the eye, and the central nervous
system (CNS), may be inﬁltrated by the larvae and manifest
as nodular mass lesions. A review from Korea revealed the
subcutaneous tissue and the CNS as the most frequently
inﬁltrated anatomic sites, accounting for 49.9% and 36.2% of
cases, respectively.8
The patient described in our case frequently travels to her
home country Thailand, where at least 62 cases have been
reported in the past 60 years. In most cases, sparganosis
presents as a single subcutaneous lesion. Of note, ocular in-
volvement due to applying frog ﬂesh poultices in traditional
FIGURE 1. Intraoperative photographs showing the extraction procedure of the parasites. This ﬁgure appears in color at www.ajtmh.org.
FIGURE 2. Histopathology of Spirometra erinaceieuropaei and the surrounding patient tissue. (A) Histopathology of S. erinaceieuropaei. Low-
magniﬁcation image of one part of the helminth (A1). Higher magniﬁcation showing the presence of typical histopathological features of cestodes
like the highly folded eosinophilic noncellular tegument (A2 andA3) and the presence of calcareous corpuscles (A2 andA4). (B) Surrounding human
tissue showing the duct of the removedhelminth in the center (B1). Chronic panniculitis (mixed inﬁltrate of lymphocytes, granulocytes, plasmacells,
foamymacrophages, and giant cells) (B2), with few eosinophils (arrows,B3). Formaldehyde-ﬁxed parafﬁn-embedded tissue sections were stained
with hematoxylin–eosin. This ﬁgure appears in color at www.ajtmh.org.
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medicinewas described in one-third of cases in Thailand up to
the 1990s. Since then, the number of such cases has de-
creased, probably because of increasing disappearance of
this practice.9,10 In general, reports on multiple lesions, like in
our case, are rare. Case reports like that of a Korean woman
with a history of eating snakes 40 years before developing
multiple masses on different body sites (e.g., breast, elbow,
and thigh) are exceptional.11
A differential diagnosis to be kept in mind for prognostic
reasons would be infection withSpirometra proliferans, where
multiple masses may occur because of the worm’s ability of
branching and budding, resulting in a more serious clinical
outcome.3,4
Multiple infections may also occur in case of local in-
oculation of the larvae due to applying poultices made out of
reptile or amphibian ﬂesh. However, our patient denied having
used this form of traditional medicine.
The patient also denied ingesting raw or undercooked
reptiles or amphibia. However, she reported drinking ﬁltered
tap water at her hometown in Thailand. Thus, the most likely
route of infection remains drinking copepod-contaminated
water, as ﬁltration might have been insufﬁcient. A review
highlighted ingestion of snakes or frogs observed in 63.4%
of the presented cases, whereas drinking unﬁltered water
accounted for 16.9% as the suspected infection route.8
Wiwanitkit identiﬁed the history of drinking “impure” water as
the main risk factor for human sparganosis in Thailand.12
Blood eosinophilia, usually suggestive of a tissue-invasive
helminth infection, was absent in our patient. This is in linewith
observations by Zhang et al.,13 who found eosinophilia in only
30% of sparganosis cases.
The initial differential diagnoses in our case were limited to
sebaceous cysts, ﬁbroma, and lipoma because typical char-
acteristics of tissue-invasive helminth infections, such as
creeping eruption/migratory swelling or blood eosinophilia,
were absent. When such characteristics are present, differ-
ential diagnoses primarily depend on epidemiology and ex-
posure. In the case of nonmigrating lesions, diroﬁlariasis or
soft tissue cysticercosis could also be considered especially
because blood eosinophilia is absent in most of these cases
too.14
Identiﬁcation ofS. erinaceieuropaei in our case is in line with
two case series from Thailand where genotyping revealed
S. erinaceieuropaei in all 12 investigated cases.9,10 The di-
agnosis is usually made by histological identiﬁcation followed
by molecular conﬁrmation of the parasite, after surgical exci-
sion. When surgery is not feasible, serology and imaging re-
main important diagnostic tools. Although the use of highly
sensitive serological assays has been described in publica-
tions from endemic regions, serological testing remains
largely unavailable inmost nonendemic settings.15 In the case
of subcutaneous sparganosis, a band-like structure may be
seen on magnetic resonance imaging. Ultrasonography may
show a coiled linear hypoechoic body in a clear oval mass.16
Species identiﬁcation is desirable so as not to miss
S. proliferum infections, which may show continued growth in
the case of incomplete removal. Histological identiﬁcation of
Sparganum spp. is based on the ﬁnding of a characteristic
FIGURE 3. Alignment of the parasite’s mitochondrial cytochrome oxidase 1 nucleotide sequence with respective reference sequences.
MK910864 = extracted parasite; MK085783 = Spirometra erinaceieuropaei; LC328900 = Spirometra decipiens; AB15753 =Sparganumproliferum.
FIGURE 4. Life cycle of Spirometra spp. This ﬁgure appears in color
at www.ajtmh.org.
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deep-folded tegument and calcareous corpuscles which are
unique to cestode tissue.17 However, in this developmental
stage of the parasite, a deﬁnitive species diagnosis can only
be achieved by molecular methods. Up to now, no standards
for molecular identiﬁcation are deﬁned. Most commonly, the
mitochondrial COX1 gene is ampliﬁed and sequenced. In this
context, it needs to be noted that ampliﬁcation and se-
quencing is based on intact DNA and that formalin (which
causes severeDNAdamage) should, therefore, be avoided for
sample preservation in such cases.
Treatment of sparganosis is primarily based on surgical
removal of the larva(e). No medical treatment standard has
been deﬁned for patients suffering from masses not suitable
for surgical resection. However, high-dose praziquantel (re-
peated cycles of 50–75 mg/kg body weight/day for 10 days)
has been reported to be effective in inoperable cases of ce-
rebral sparganosis.13,18
In summary, human infections with Spirometra spp. are
rare, usually not considered outside endemic regions, and
as in the case presented, diagnosis is only made after surgi-
cal removal of the parasite. There is a lack of commercially
available serological tests, and species identiﬁcation requires
sequencing.
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